From product launches to acquisitions, here are seven updates from Medtronic so far in 2025.
1. Medtronic acquired rights and intellectual property related to Nanovis’ Sites Medical’s OsteoSync titanium pads.
2. The company was included on Fortune’s annual list of the World’s Most Admired Companies.
3. Thierry Piéton was appointed as Medtronic’s next CFO.
4. Medtronic and Kuros Biosciences signed a strategic agreement to support sales of the MagnetOs bone graft technology.
5. Medtronic saw $8.3 billion in revenue during the third quarter of fiscal year 2025, according to financial results posted Feb. 18.
6. Medtronic launched the CD Horizon ModuLeX spinal system for deformity surgery.7. Medtronic was included on the 2025 “World’s Most Ethical” list from Ethisphere.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
